BioNet News 05 May 2025 Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda Copy Despite a decrease in infections caused by Bordetella pertussis due to COVID-19 pandemic, booster vaccination of pregnant women is still recommended to… Pantitra
BioNet News 28 Feb 2025 Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-Diphtheria Pertussis is a highly contagious infectious disease of the respiratory tract caused by Bordetella pertussis. Disease is most severe in young… Pantitra
BioNet News 31 Dec 2024 A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial Pertussis, also known as whooping cough, is an acute respiratory disease caused by Bordetella pertussis, a bacterium that is transmitted between… Pantitra
